Optimal SARS-CoV-2 vaccine allocation using real-time seroprevalence estimates in Rhode Island and Massachusetts. Author(s): Tran TN, Wikle N, Albert J, Inam H, Strong E, Břinda K, Leighow SM, Yang F, Hossain S, Pritchard JR, Chan P, Hanage WP, Hanks EM, Boni MF|Journal: medRxiv|PMID: 33469599| January 2021 As three SARS-CoV-2 vaccines come to market in Europe and North America in the winter of 2020-2021, distribution networks will…
